Optimal treatment for lumbar spinal stenosis: an update

被引:16
作者
Patel, Janus [1 ]
Osburn, Ian [1 ]
Wanaselja, Anne [1 ]
Nobles, Ryan [2 ]
机构
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Southeastern Spine Inst, 1106 Chuck Dawley Blvd 200, Mt Pleasant, SC 29464 USA
关键词
epidural steroid injection; lumbar spinal stenosis; mild; spinal cord stimulator; NONOPERATIVE TREATMENT; OUTCOMES; RADICULOPATHY; GABAPENTIN; EFFICACY; THERAPY; SURGERY; AGENTS; TRIAL; SCANS;
D O I
10.1097/ACO.0000000000000495
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose of review Our review of current literature within the past 12-24 months for the treatment of lumbar spinals stenosis (LSS) serves to update providers on recent advances and comparisons regarding therapy spanning lifestyle modification, pharmacologic therapy, minimally invasive interventions, and surgical interventions. Recent findings Current literature supporting the inclusion of physical therapy and gabapentin/pregabalin within an initial treatment regimen have been positive. A recent randomized, double-blinded clinical trial of adding calcitonin to epidural steroid injections have shown improvement in pain and function up to 1 year. The minimally invasive lumbar decompression (mild) procedure is showing ongoing beneficial results in pain and function. Spinal cord stimulation (SCS) may have a role for select patients with lumbar spinal stenosis. Finally, the benefits of surgical treatment versus nonsurgical treatment is ultimately inconclusive because of the nature of data collection, inconsistencies with the clinical definition of LSS, and a lack of standardized treatment guidelines. Summary Our review of current research demonstrates there is a positive role for the current conservative therapies, with favorable results for interventions such as minimally invasive decompression and SCS. Pharmacologic interventions such as systemic prostaglandin analogues and epidural agents such as calcitonin demonstrate early promise, but need to undergo additional safety testing and confirmatory trials. Further long-term research with validated, objective measurements for the aforementioned treatments are needed to draw any definitive conclusions for clinical practice.
引用
收藏
页码:598 / 603
页数:6
相关论文
共 39 条
  • [1] Nonoperative treatment for lumbar spinal stenosis with neurogenic claudication
    Ammendolia, Carlo
    Stuber, Kent J.
    Rok, Elisabeth
    Rampersaud, Raja
    Kennedy, Carol A.
    Pennick, Victoria
    Steenstra, Ivan A.
    de Bruin, Linda K.
    Furlan, Andrea D.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [2] [Anonymous], LIMAPROST DRUGS
  • [3] [Anonymous], LIMAPROST DRUGS
  • [4] [Anonymous], SPINE PHILA PA 1976
  • [5] [Anonymous], SPINE PHILA PA 1976
  • [6] [Anonymous], PRACTICAL MANAGEMENT
  • [7] ARNOLDI CC, 1976, CLIN ORTHOP RELAT R, P4
  • [8] Membrane-Stabilizing Agents Improve Quality-of-Life Outcomes for Patients with Lumbar Stenosis
    Bansal, Sachin
    Lubelski, Daniel
    Thompson, Nicolas R.
    Shah, Ali A.
    Mazanec, Daniel J.
    Benzel, Edward C.
    Khalaf, Tagreed
    [J]. GLOBAL SPINE JOURNAL, 2016, 6 (02) : 139 - 146
  • [9] Benyamin RM, 2016, PAIN PHYSICIAN, V19, P229
  • [10] Benyamin RM, 2015, PAIN PHYSICIAN, V18, P307